2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Aug 23, 2022.
-11.3% median (-11.3% mean) 90-day return after 2 previous buys.
The trade is 0.3% of the 349,000 shares held after it.
No other insider bought within 30 days.
165 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Patel Paresh bought about $114.9K of HCI on Apr 9, 2024, the largest insider purchase at the company since 2022; 165 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Apr 5, 2024.
The trade is 69.6% of the 30,000 shares held after it.
4 other insiders sold within 30 days.
165 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Division President Saravanos Anthony sold about $2.4M of HCI on Apr 8, 2024; 4 other insiders sold within 30 days and 165 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Mar 28, 2024.
The trade is 6.2% of the 50,873 shares held after it.
4 other insiders sold within 30 days.
165 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Division President Saravanos Anthony sold about $363.4K of HCI on Apr 5, 2024; 4 other insiders sold within 30 days and 165 funds added in the latest 13F quarter.
8 earlier Form 4 trades (code P or S) here by this insider (2 buys, 6 sales), the last on Apr 3, 2024.
+21.8% median (+21.8% mean) 90-day return after 2 previous buys.
4 other insiders sold within 30 days.
165 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: General Counsel Graham Andrew L. sold about $329.6K of HCI on Apr 4, 2024; 4 other insiders sold within 30 days and 165 funds added in the latest 13F quarter.
33 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
HCI planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
HCI mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Allspring SMID Core ETF
$1.6M position · as of 2026-06-30
1.4%
1290 Essex Small Cap Growth Fund
$1.1M position · as of 2026-07-31
1.0%
Inspire Fidelis Multi Factor ETF
$1.8M position · as of 2026-05-31
0.9%
Applied Finance Explorer Fund
$8.2M position · as of 2026-07-31
0.8%
Invesco S&P Smallcap 600 Pure Growth ETF
$1.1M position · as of 2026-07-31
0.8%
S&P SmallCap 600 Pure Growth Fund
$470.9K position · as of 2026-06-30
0.8%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Paresh Patel
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$8.2M
$55.3M
$935.0K
+306%
+32%
2024
$20.2M
$21.5M
$709.4K
+144%
+18%
2023
$3.7M
$8.5M
$498.5K
+80%
-30%
2022
$1.0M
-$23.9M
$450.1K
-21%
-69%
2021
$7.7M
$29.1M
$2.8M
+63%
-49%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 165 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$952.1M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM HCI
FY Dec 2025
$900.9M
FY Dec 2024
$750.1M
FY Dec 2023
$550.7M
FY Dec 2022
$499.6M
FY Dec 2021
$407.9M
Jun 2026
$246.7M
Mar 2026
$242.9M
Dec 2025
$246.2M
Sep 2025
$216.3M
Jun 2025
$221.9M
Mar 2025
$216.4M
Dec 2024
$161.9M
Sep 2024
$175.3M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM HCI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+29.9%
Mar 2026
+30.2%
Dec 2025
+43.9%
Sep 2025
+30.3%
Jun 2025
+29.8%
Mar 2025
+32.2%
Dec 2024
+2.6%
Sep 2024
+3.2%
At each fiscal year end
Single quarter
Free cash flow, TTM
$409.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM HCI
FY Dec 2025
$440.8M
FY Dec 2024
$327.8M
FY Dec 2023
$224.2M
FY Dec 2022
-$6.4M
FY Dec 2021
$93.2M
Jun 2026
$124.8M
Mar 2026
$148.5M
Dec 2025
$110.2M
Sep 2025
$25.9M
Jun 2025
$144.5M
Mar 2025
$160.3M
Dec 2024
$73.6M
Sep 2024
$103.2M
At each fiscal year end
Single quarter
Debt to equity
0.23x
long-term debt only, 2018-09-30 (94 months older than the period end); equity 2026-06-30
Debt to equity HCI
FY Dec 2025
0.24x
FY Dec 2024
0.55x
FY Dec 2023
0.77x
FY Dec 2022
1.53x
FY Dec 2021
0.77x
Jun 2026
0.23x
Mar 2026
0.23x
Dec 2025
0.24x
Sep 2025
0.30x
Jun 2025
0.33x
Mar 2025
0.48x
Dec 2024
0.55x
Sep 2024
0.55x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.66x
TTM operating cash flow over long-term debt only, 2018-09-30 (94 months older than the period end)
Cash flow to debt HCI
FY Dec 2025
1.79x
FY Dec 2024
1.34x
FY Dec 2023
0.93x
FY Dec 2022
-0.00x
FY Dec 2021
0.39x
Jun 2026
1.66x
Mar 2026
1.74x
Dec 2025
1.79x
Sep 2025
1.64x
Jun 2025
1.95x
Mar 2025
1.25x
Dec 2024
1.34x
Sep 2024
1.65x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on equity HCI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on assets HCI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital HCI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed HCI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
8.75x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing HCI
FY Dec 2025
8.45x
FY Dec 2024
13.24x
FY Dec 2023
11.56x
FY Dec 2022
n/a
FY Dec 2021
298.36x
Jun 2026
7.55x
Mar 2026
6.79x
Dec 2025
8.45x
Sep 2025
12.26x
Jun 2025
13.49x
Mar 2025
14.43x
Dec 2024
13.24x
Sep 2024
8.94x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.9B
market value at close 2026-10-26 on 2026-08-03 shares, plus long-term debt only, 2018-09-30 (94 months older than the period end), minus cash 2026-06-30
Enterprise value HCI
FY Dec 2025
$1.5B
FY Dec 2024
$944.0M
FY Dec 2023
$462.7M
FY Dec 2022
$360.4M
FY Dec 2021
$475.9M
Jun 2026
$1.6B
Mar 2026
$1.2B
Dec 2025
$1.5B
Sep 2025
$1.7B
Jun 2025
$1.1B
Mar 2025
$1.1B
Dec 2024
$944.0M
Sep 2024
$851.0M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+16.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield HCI
FY Dec 2025
+17.7%
FY Dec 2024
+26.7%
FY Dec 2023
+29.9%
FY Dec 2022
-1.8%
FY Dec 2021
+10.9%
Jun 2026
+18.3%
Mar 2026
+21.4%
Dec 2025
+17.7%
Sep 2025
+16.3%
Jun 2025
+27.4%
Mar 2025
+19.1%
Dec 2024
+26.7%
Sep 2024
+36.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.08x
P/E over trailing EPS growth of 106%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing HCI
FY Dec 2025
0.05x
FY Dec 2024
0.81x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.07x
Mar 2026
0.06x
Dec 2025
0.05x
Sep 2025
0.40x
Jun 2025
n/a
Mar 2025
2.78x
Dec 2024
0.81x
Sep 2024
0.05x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
HCI ranks highest on financial health (69th percentile) and growth (68th), and lowest on risk and compliance (44th), among Insurance peers.
Financial health
69
Inputs
Debt to equity0.23x · 59 pct, sector of 104
Cash flow to debt1.66x · 79 pct, sector of 97
Growth
68
Inputs
Revenue growth, YoY+20.1% · 68 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
52
Inputs
Funds adding, latest quarter165 · 52 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
44
Inputs
Short interest, % of float+5.0% · 33 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+9.8% · 56 pct, sector of 110
3 not measured: Profitability, Insider conviction, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of operating income; the filed year and its quarters do not reconcile, so the trailing figure is withheld
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.